0001492658-17-000046.txt : 20170907 0001492658-17-000046.hdr.sgml : 20170907 20170907190103 ACCESSION NUMBER: 0001492658-17-000046 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170905 FILED AS OF DATE: 20170907 DATE AS OF CHANGE: 20170907 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cooke Peter CENTRAL INDEX KEY: 0001577002 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35065 FILM NUMBER: 171074863 MAIL ADDRESS: STREET 1: 5677 AIRLINE ROAD CITY: ARLINGTON STATE: TN ZIP: 38002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Wright Medical Group N.V. CENTRAL INDEX KEY: 0001492658 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 980509600 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1227 BUSINESS ADDRESS: STREET 1: PRINS BERNHARDPLEIN 200 CITY: AMSTERDAM STATE: P7 ZIP: 1097JB BUSINESS PHONE: 901-867-4317 MAIL ADDRESS: STREET 1: 1023 CHERRY ROAD CITY: MEMPHIS STATE: TN ZIP: 38117 FORMER COMPANY: FORMER CONFORMED NAME: Tornier N.V. DATE OF NAME CHANGE: 20110201 FORMER COMPANY: FORMER CONFORMED NAME: Tornier B.V. DATE OF NAME CHANGE: 20100524 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2017-09-05 0 0001492658 Wright Medical Group N.V. WNGI 0001577002 Cooke Peter 1023 CHERRY ROAD MEMPHIS TN 38117 0 1 0 0 President, International Ordinary Shares, par value EUR 0.03 per Share 2017-09-05 4 M 0 7875 21.24 A 52488 D Ordinary Shares, par value EUR 0.03 per share 2017-09-05 4 M 0 29710 20.62 A 82198 D Ordinary Shares, par value EUR 0.03 per share 2017-09-05 4 M 0 45 20.21 A 82243 D Ordinary Shares, par value EUR 0.03 per share 2017-09-05 4 S 0 37630 D 44613 D Ordinary Shares, par value EUR 0.03 per share 2017-09-06 4 M 0 54077 20.21 A 98690 D Ordinary Shares, par value EUR 0.03 per share 2017-09-06 4 S 0 72131 D 26559 D Ordinary Shares, par value EUR 0.03 per share 2017-09-07 4 S 0 2934 D 23625 D Stock Option (right to buy) 21.24 2017-09-05 4 M 0 7875 21.24 D 2026-07-19 Ordinary Shares 7875 21208 D Stock Option (right to buy) 20.62 2017-09-05 4 M 0 29710 20.62 D 2025-10-13 Ordinary Shares 29710 35160 D Stock Option (right to buy) 20.21 2017-09-05 4 M 0 45 20.21 D 2023-01-31 Ordinary Shares 45 54077 D Stock Option (right to buy) 20.21 2017-09-06 4 M 0 54077 20.21 D 2023-01-31 Ordinary Shares 54077 0 D Includes 18,801 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 4,824 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.15 to $29.58, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.63 inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.68 to $29.10 inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. This option vests with respect to 25% of the shares on July 19, 2017 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. This option vests with respect to 25% of the shares on October 13, 2016 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. These shares vested on October 1, 2015. /s/Marija Nelson, attorney-in-fact 2017-09-07